Health Care Providers & Services · NYSE

CORCencora, Inc.

Last close
$359.03 +2.8%
52-week range
$244.82 to $377.54
Market cap
$68.5B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$321B
+9% vs FY24
Net income
$1.55B
+3% vs FY24
Free cash flow
$3.21B
+7% vs FY24
Net cash
-$3.30B
Cash $4.36B, debt $7.66B

Stock price

+355% since Dec 2016

Valuation vs its own 10 years

Above its 10-year median on all 3 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
26.7x
11.6x51.1x
77th percentile, above its median of 20.8x
Positive-earnings quarters only
Price / sales
0.2x
0.1x0.2x
Highest point in its range, above its median of 0.1x
EV / EBITDA
19.0x
n/a: Not enough history
Price / free cash flow
16.9x
7.5x51.3x
74th percentile, above its median of 13.3x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-06-30. Every figure carries its unit.

Valuation

P/E
26.7x
Earnings yield
3.8%
Price / sales
0.2x
Price / book
22.5x
Price / operating cash flow
14.2x
EV / EBITDA
19.0x
EV / sales
0.2x
Free cash flow yield
5.9%

Profitability

Gross margin
4.0%
Operating margin
0.9%
Net margin
0.8%
Return on equity
86.0%
Return on capital
15.1%

Growth per year

Revenue, 3 years
+10.4%
Revenue, 5 years
+11.1%
Revenue, 9 years
+9.1%
EPS, 3 years
-0.3%

Balance sheet

Cash and investments
$2.82B
Total debt
$11.7B
Net cash
-$8.91B
Debt / equity
3.84x
Current ratio
0.93x

Shares and dividend

Shares outstanding
191M
Share count, 5 years
-4.7%
Beta, 1 year
0.05
Dividend yield
0.7%
Dividend per share, TTM
$2.35
Payout ratio
17.8%

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $84.8B
RevenueNet income
Gross profitLatest quarter $3.61B
EBITDALatest quarter $1.39B
Margins4 / 1 / 1%
GrossOperatingNet
Earnings per shareLatest quarter $3.94
Cash flowLatest quarter $2.65B
OperatingCapexFree
Cash vs debtLatest quarter $2.82B
Cash and investmentsTotal debt
P/E historyNow 26.7x
P/E, median 20.8x dashed
P/S historyNow 0.2x
P/S, median 0.1x dashed

Health Care Providers & Services peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
UNH Unitedhealth Group Inc $365B +3% 5.3%23.3x0.8x 68th percentile
MCK Mckesson Corp $127B +8% 1.6%28.4x0.3x 78th percentile
CVS CVS HEALTH Corp $114B +7% 3.6%10.4x0.3x 10th percentile
HCA HCA Healthcare, Inc. $104B +6% n/a16.5x1.3x 95th percentile
ELV Elevance Health, Inc. $92.8B +4% 2.7%18.3x0.5x 70th percentile
COR Cencora, Inc. $68.5B +5% 0.9%26.7x0.2x 77th percentile

The company

Sector
Health Care
Industry
Health Care Providers & Services
CEO
Steven H. Collis
Employees
44,000 (as of 2022)
Founded
2001
Headquarters
Conshohocken, PA
Fiscal year ends
September
Website
cencora.com

What it does

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about COR.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 1,047 active funds. Crowd level: quiet.

Open the Smart money tab